{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:02:45Z","timestamp":1779930165045,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008486","name":"Schweizerische Multiple Sklerose Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008486","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stiftung f\u00fcr Ergotherapie"},{"name":"Grenzen \u00fcberschreiten"},{"name":"Blumenau-L\u00e9onie Hartmann-Stiftung","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1267-9","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T09:03:46Z","timestamp":1552035826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Influence of different rehabilitative aerobic exercise programs on (anti-) inflammatory immune signalling, cognitive and functional capacity in persons with MS \u2013 study protocol of a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Niklas","family":"Joisten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Dalgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Caminada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette-Triin","family":"Purde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gonzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1474-4422(17)30281-8","volume":"16","author":"RW Motl","year":"2017","unstructured":"Motl RW, Sandroff BM, Kwakkel G, Dalgas U, Feinstein A, Heesen C, et al. Exercise in patients with multiple sclerosis. Lancet Neurol. 2017;16:848\u201356. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30281-8 \n                    \n                  .","journal-title":"Lancet Neurol"},{"key":"1267_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/nmt-2017-0040","volume":"7","author":"U Dalgas","year":"2017","unstructured":"Dalgas U. Exercise therapy in multiple sclerosis and its effects on function and the brain. Neurodegener Dis Manag. 2017;7:35\u201340. \n                    https:\/\/doi.org\/10.2217\/nmt-2017-0040 \n                    \n                  .","journal-title":"Neurodegener Dis Manag"},{"key":"1267_CR3","doi-asserted-by":"publisher","unstructured":"Kj\u00f8lhede T, Siemonsen S, Wenzel D, Stellmann J-P, Ringgaard S, Pedersen BG, et al. Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis? Mult Scler. 2017:1352458517722645. \n                    https:\/\/doi.org\/10.1177\/1352458517722645 \n                    \n                  .","DOI":"10.1177\/1352458517722645"},{"key":"1267_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/1756285611430719","volume":"5","author":"U Dalgas","year":"2012","unstructured":"Dalgas U, Stenager E. Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord. 2012;5:81\u201395. \n                    https:\/\/doi.org\/10.1177\/1756285611430719 \n                    \n                  .","journal-title":"Ther Adv Neurol Disord"},{"key":"1267_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nbd.2009.06.013","volume":"36","author":"S Rossi","year":"2009","unstructured":"Rossi S, Furlan R, de CV, Musella A, Lo Giudice T, Mataluni G, et al. Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiol Dis. 2009;36:51\u20139. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2009.06.013 \n                    \n                  .","journal-title":"Neurobiol Dis"},{"key":"1267_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI5150","volume":"103","author":"TL Sorensen","year":"1999","unstructured":"Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999;103:807\u201315. \n                    https:\/\/doi.org\/10.1172\/JCI5150 \n                    \n                  .","journal-title":"J Clin Invest"},{"issue":"Suppl 2","key":"1267_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ene.12798","volume":"22","author":"N Grigoriadis","year":"2015","unstructured":"Grigoriadis N, van Pesch V. A basic overview of multiple sclerosis immunopathology. Eur J Neurol. 2015;22(Suppl 2):3\u201313. \n                    https:\/\/doi.org\/10.1111\/ene.12798 \n                    \n                  .","journal-title":"Eur J Neurol"},{"key":"1267_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/109502","volume":"2008","author":"N Mathur","year":"2008","unstructured":"Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Mediat Inflamm. 2008;2008:109502. \n                    https:\/\/doi.org\/10.1155\/2008\/109502 \n                    \n                  .","journal-title":"Mediat Inflamm"},{"key":"1267_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6789276.","volume":"2016","author":"N Deckx","year":"2016","unstructured":"Deckx N, Wens I, Nuyts AH, Hens N, Winter BY d, Koppen G, et al. 12 weeks of combined endurance and resistance training reduces innate markers of inflammation in a randomized controlled clinical trial in patients with multiple sclerosis. Mediat Inflamm. 2016;2016:6789276. \n                    https:\/\/doi.org\/10.1155\/2016\/6789276\n                    \n                  .","journal-title":"Mediat Inflamm"},{"key":"1267_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12020-017-1337-y","volume":"57","author":"M Mokhtarzade","year":"2017","unstructured":"Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFalpha, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine. 2017;57:262\u201371. \n                    https:\/\/doi.org\/10.1007\/s12020-017-1337-y \n                    \n                  .","journal-title":"Endocrine."},{"key":"1267_CR11","doi-asserted-by":"publisher","unstructured":"Zimmer P, Bloch W, Schenk A, Oberste M, Riedel S, Kool J, et al. High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: a randomized controlled trial. Mult Scler. 2017:1352458517728342. \n                    https:\/\/doi.org\/10.1177\/1352458517728342 \n                    \n                  .","DOI":"10.1177\/1352458517728342"},{"key":"1267_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000369933","volume":"15","author":"M Fakhoury","year":"2015","unstructured":"Fakhoury M. Role of immunity and inflammation in the pathophysiology of neurodegenerative diseases. Neurodegener Dis. 2015;15:63\u20139. \n                    https:\/\/doi.org\/10.1159\/000369933 \n                    \n                  .","journal-title":"Neurodegener Dis"},{"issue":"Suppl 3","key":"1267_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sms.12581","volume":"25","author":"BK Pedersen","year":"2015","unstructured":"Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1\u201372. \n                    https:\/\/doi.org\/10.1111\/sms.12581 \n                    \n                  .","journal-title":"Scand J Med Sci Sports"},{"key":"1267_CR14","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/acn3.580","volume":"5","author":"BA Racette","year":"2018","unstructured":"Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles Nielsen S. Immunosuppressants and risk of Parkinson disease. Ann Clin Transl Neurol. 2018;5:870\u20135. \n                    https:\/\/doi.org\/10.1002\/acn3.580 \n                    \n                  .","journal-title":"Ann Clin Transl Neurol"},{"key":"1267_CR15","doi-asserted-by":"publisher","unstructured":"Hanken K, Eling P, Hildebrandt H. The representation of inflammatory signals in the brain \u2013 a model for subjective fatigue in multiple sclerosis. Front Neurol. 2014. \n                    https:\/\/doi.org\/10.3389\/fneur.2014.00264 \n                    \n                  .","DOI":"10.3389\/fneur.2014.00264"},{"key":"1267_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14:232\u201344. \n                    https:\/\/doi.org\/10.1111\/obr.12003 \n                    \n                  .","journal-title":"Obes Rev"},{"key":"1267_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/cphy.c160042","volume":"7","author":"LP Bharath","year":"2017","unstructured":"Bharath LP, Ip BC, Nikolajczyk BS. Adaptive immunity and metabolic health: harmony becomes dissonant in obesity and aging. Compr Physiol. 2017;7:1307\u201337. \n                    https:\/\/doi.org\/10.1002\/cphy.c160042 \n                    \n                  .","journal-title":"Compr Physiol"},{"key":"1267_CR18","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.jaci.2015.10.035","volume":"137","author":"M Weinhold","year":"2016","unstructured":"Weinhold M, Shimabukuro-Vornhagen A, Franke A, Theurich S, Wahl P, Hallek M, et al. Physical exercise modulates the homeostasis of human regulatory T cells. J Allergy Clin Immunol. 2016;137:1607\u20131610.e8. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2015.10.035 \n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"1267_CR19","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1002\/eji.201242572","volume":"42","author":"F Fallarino","year":"2012","unstructured":"Fallarino F, Grohmann U, Puccetti P. Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol. 2012;42:1932\u20137. \n                    https:\/\/doi.org\/10.1002\/eji.201242572 \n                    \n                  .","journal-title":"Eur J Immunol"},{"key":"1267_CR20","doi-asserted-by":"publisher","unstructured":"Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science. 2017. \n                    https:\/\/doi.org\/10.1126\/science.aaf9794 \n                    \n                  .","DOI":"10.1126\/science.aaf9794"},{"key":"1267_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1152\/japplphysiol.00656.2003","volume":"96","author":"MS Tremblay","year":"2004","unstructured":"Tremblay MS, Copeland JL, van Helder W. Effect of training status and exercise mode on endogenous steroid hormones in men. J Appl Physiol. 2004;96:531\u20139. \n                    https:\/\/doi.org\/10.1152\/japplphysiol.00656.2003 \n                    \n                  .","journal-title":"J Appl Physiol"},{"key":"1267_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuropharm.2015.11.015","volume":"112","author":"B AA-B","year":"2017","unstructured":"AA-B B. Tryptophan availability for kynurenine pathway metabolism across the life span: control mechanisms and focus on aging, exercise, diet and nutritional supplements. Neuropharmacology. 2017;112:248\u201363. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2015.11.015 \n                    \n                  .","journal-title":"Neuropharmacology."},{"key":"1267_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","volume":"364","author":"K Schrocksnadel","year":"2006","unstructured":"Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta. 2006;364:82\u201390. \n                    https:\/\/doi.org\/10.1016\/j.cca.2005.06.013 \n                    \n                  .","journal-title":"Clin Chim Acta"},{"key":"1267_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fimmu.2014.00673","volume":"5","author":"M Platten","year":"2014","unstructured":"Platten M, von Knebel Doeberitz N, Oezen I, Wick W, Ochs K. Cancer immunotherapy by targeting IDO1\/TDO and their downstream effectors. Front Immunol. 2014;5:673. \n                    https:\/\/doi.org\/10.3389\/fimmu.2014.00673 \n                    \n                  .","journal-title":"Front Immunol"},{"key":"1267_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","volume":"40","author":"DC Maddison","year":"2015","unstructured":"Maddison DC, Giorgini F. The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol. 2015;40:134\u201341. \n                    https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002 \n                    \n                  .","journal-title":"Semin Cell Dev Biol"},{"key":"1267_CR26","doi-asserted-by":"publisher","unstructured":"Lovelace MD, Varney B, Sundaram G, Franco NF, Ng ML, Pai S, et al. Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis. Front Immunol. 2016. \n                    https:\/\/doi.org\/10.3389\/fimmu.2016.00246 \n                    \n                  .","DOI":"10.3389\/fimmu.2016.00246"},{"key":"1267_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","volume":"112","author":"H Fujigaki","year":"2017","unstructured":"Fujigaki H, Yamamoto Y, Saito K. L-tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences. Neuropharmacology. 2017;112:264\u201374. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.011 \n                    \n                  .","journal-title":"Neuropharmacology."},{"key":"1267_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","volume":"159","author":"LZ Agudelo","year":"2014","unstructured":"Agudelo LZ, Femen\u00eda T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, et al. Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159:33\u201345. \n                    https:\/\/doi.org\/10.1016\/j.cell.2014.07.051 \n                    \n                  .","journal-title":"Cell."},{"key":"1267_CR29","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/npp.2011.127","volume":"36","author":"A Pocivavsek","year":"2011","unstructured":"Pocivavsek A, Wu H-Q, Potter MC, Elmer GI, Pellicciari R, Schwarcz R. Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory. Neuropsychopharmacology. 2011;36:2357\u201367. \n                    https:\/\/doi.org\/10.1038\/npp.2011.127 \n                    \n                  .","journal-title":"Neuropsychopharmacology."},{"key":"1267_CR30","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230","volume":"169","author":"TW Stone","year":"2013","unstructured":"Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol. 2013;169:1211\u201327. \n                    https:\/\/doi.org\/10.1111\/bph.12230 \n                    \n                  .","journal-title":"Br J Pharmacol"},{"key":"1267_CR31","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/124.9.1743","volume":"124","author":"RL Lindberg","year":"2001","unstructured":"Lindberg RL, de GCJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain. 2001;124:1743\u201353.","journal-title":"Brain."},{"key":"1267_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302. \n                    https:\/\/doi.org\/10.1002\/ana.22366 \n                    \n                  .","journal-title":"Ann Neurol"},{"key":"1267_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444\u201352.","journal-title":"Neurology."},{"key":"1267_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0197-2456(02)00242-8","volume":"23","author":"NW Scott","year":"2002","unstructured":"Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. A review. Control Clin Trials. 2002;23:662\u201374.","journal-title":"Control Clin Trials"},{"key":"1267_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/ejh.12561","volume":"96","author":"P Zimmer","year":"2016","unstructured":"Zimmer P, Baumann FT, Bloch W, Zopf EM, Schulz S, Latsch J, et al. Impact of a half marathon on cellular immune system, pro-inflammatory cytokine levels, and recovery behavior of breast cancer patients in the aftercare compared to healthy controls. Eur J Haematol. 2016;96:152\u20139. \n                    https:\/\/doi.org\/10.1111\/ejh.12561 \n                    \n                  .","journal-title":"Eur J Haematol"},{"key":"1267_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0033-1343395","volume":"121","author":"P Wenning","year":"2013","unstructured":"Wenning P, Kreutz T, Schmidt A, Opitz D, Graf C, Voss S, et al. Endurance exercise alters cellular immune status and resistin concentrations in men suffering from non-insulin-dependent type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013;121:475\u201382. \n                    https:\/\/doi.org\/10.1055\/s-0033-1343395 \n                    \n                  .","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1267_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, et al. Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler. 2012;18:891\u20138. \n                    https:\/\/doi.org\/10.1177\/1352458511431076 \n                    \n                  .","journal-title":"Mult Scler"},{"key":"1267_CR38","unstructured":"Becker M, Sturm W, Willmes K, Zimmermannn P. Normierungsstudie zur Aufmerksamkeitstestbatterie (TAP) von Zimmermann und Fimm. Z Neuropsychol. 1996:3\u201315."},{"key":"1267_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00415-003-1025-0","volume":"250","author":"I-K Penner","year":"2003","unstructured":"Penner I-K, Rausch M, Kappos L, Opwis K, Rad\u00fc EW. Analysis of impairment related functional architecture in MS patients during performance of different attention tasks. J Neurol. 2003;250:461\u201372. \n                    https:\/\/doi.org\/10.1007\/s00415-003-1025-0 \n                    \n                  .","journal-title":"J Neurol"},{"key":"1267_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186774","volume":"12","author":"R Littman","year":"2017","unstructured":"Littman R, Tak\u00e1cs \u00c1. Do all inhibitions act alike? A study of go\/no-go and stop-signal paradigms. PLoS One. 2017;12:e0186774. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0186774 \n                    \n                  .","journal-title":"PLoS One"},{"key":"1267_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2182\/cjot.2012.79.3.6","volume":"79","author":"AM Fioravanti","year":"2012","unstructured":"Fioravanti AM, Bordignon CM, Pettit SM, Woodhouse LJ, Ansley BJ. Comparing the responsiveness of the assessment of motor and process skills and the functional independence measure. Can J Occup Ther. 2012;79:167\u201374. \n                    https:\/\/doi.org\/10.2182\/cjot.2012.79.3.6 \n                    \n                  .","journal-title":"Can J Occup Ther"},{"key":"1267_CR42","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1352458512458605","volume":"19","author":"J Bansi","year":"2013","unstructured":"Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler. 2013;19:613\u201321. \n                    https:\/\/doi.org\/10.1177\/1352458512458605 \n                    \n                  .","journal-title":"Mult Scler"},{"key":"1267_CR43","volume-title":"Principles of exercise testing and interpretation: including pathophysiology and clinical applications","author":"K Wasserman","year":"2005","unstructured":"Wasserman K. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.","edition":"4"},{"key":"1267_CR44","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner IK, Raselli C, Stocklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 2009;15:1509\u201317. \n                    https:\/\/doi.org\/10.1177\/1352458509348519 \n                    \n                  .","journal-title":"Mult Scler"},{"key":"1267_CR45","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1024\/1661-4747\/a000077","volume":"59","author":"F Petermann","year":"2011","unstructured":"Petermann F. Hospital anxiety and depression scale, deutsche version (HADS-D). Z Psychiatr Psychol Psychother. 2011;59:251\u20133. \n                    https:\/\/doi.org\/10.1024\/1661-4747\/a000077 \n                    \n                  .","journal-title":"Z Psychiatr Psychol Psychother"},{"key":"1267_CR46","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18:873\u201380. \n                    https:\/\/doi.org\/10.1007\/s11136-009-9496-9 \n                    \n                  .","journal-title":"Qual Life Res"},{"key":"1267_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"1267_CR48","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jclinepi.2007.02.006","volume":"60","author":"GF Borm","year":"2007","unstructured":"Borm GF, Fransen J, Lemmens WAJG. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234\u20138. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2007.02.006 \n                    \n                  .","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1267-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:10:43Z","timestamp":1583539843000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1267-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"27 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Swiss Ethics Committee \u201cOstschweiz\u201d (EKOS) on research involving humans (EKOS18\/96; Project ID: 2018\u201301378). Prior to study participation, a written consent form will be signed by each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"37"}}